会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • Combination Imaging and Therapy Transducer With Therapy Transducer Amplifier
    • 组合成像和治疗传感器与治疗传感器放大器
    • US20080228075A1
    • 2008-09-18
    • US12064309
    • 2006-08-25
    • John FraserJeffry E. PowersMichalakis Averkiou
    • John FraserJeffry E. PowersMichalakis Averkiou
    • A61B8/00
    • A61B17/22004A61B8/0833A61B8/14A61B8/4405A61B8/481A61B17/2256A61B2017/22028A61B2090/378G01S15/8918G01S15/8977
    • A combined ultrasound imaging and therapy transducer (10) includes a linear array of imaging transducer elements (14). First and second linear arrays of therapy transducer elements (18, 20) extend longitudinally along respective first and second sides of the imaging transducer elements and are canted inwardly toward each other. The imaging and therapy transducer is used with an ultrasound imaging system to locate clots in a region of interest. After the region of interest has been perfused with a microbubble contrast agent, the therapy transducer elements are driven by an amplifier located in the transducer to dissolve the clot. The use of the imaging transducer elements and the therapy transducer elements can be interleaved so that the therapy can be conditioned on an ultrasound image showing substantial destruction of the contrast agent microbubbles, re-perfusion of microbubbles in the region of interest, or the continued presence of the clot.
    • 组合的超声成像和治疗换能器(10)包括成像换能器元件(14)的线性阵列。 治疗换能器元件(18,20)的第一和第二线性阵列沿着成像换能器元件的相应的第一和第二侧纵向延伸并且向内朝向彼此倾斜。 成像和治疗传感器与超声成像系统一起使用以定位感兴趣区域中的凝块。 在用微泡造影剂灌注感兴趣区域之后,治疗换能器元件由位于换能器中的放大器驱动以溶解凝块。 可以使用成像换能器元件和治疗换能器元件进行交织,使得治疗可以对超声图像进行调节,该超声图像显示造影剂微泡的显着破坏,感兴趣区域中微泡的再次灌注,或持续存在 的凝块。
    • 8. 发明授权
    • Method of using a combination imaging and therapy transducer to dissolve blood clots
    • 使用组合成像和治疗传感器来溶解血块的方法
    • US08012092B2
    • 2011-09-06
    • US12065343
    • 2006-08-25
    • Jeffry E. PowersJohn FraserMichalakis Averkiou
    • Jeffry E. PowersJohn FraserMichalakis Averkiou
    • A61B8/14A61B7/00
    • A61N7/02A61B8/0833A61B8/14A61B8/4405A61B8/481A61B2017/22008A61B2090/378A61N2007/0078
    • A combined ultrasound imaging and therapy transducer includes a linear array of imaging transducer elements. First and second linear arrays of therapy transducer elements extend longitudinally along respective first and second sides of the imaging transducer elements and are canted inwardly toward each other. The imaging and therapy transducer is used with an ultrasound imaging system to locate clots in a region of interest. After the region of interest has been perfused with a microbubble contrast agent, the therapy transducer elements are driven by an amplifier located in the transducer to dissolve the clot. The use of the imaging transducer elements and the therapy transducer elements can be interleaved so that the therapy can be conditioned on an ultrasound image showing substantial destruction of the contrast agent microbubbles, re-perfusion of microbubbles in the region of interest, or the continued presence of the clot.
    • 组合的超声成像和治疗换能器包括成像换能器元件的线性阵列。 治疗换能器元件的第一和第二线性阵列沿着成像换能器元件的相应第一和第二侧纵向延伸并且向内朝向彼此倾斜。 成像和治疗传感器与超声成像系统一起使用以定位感兴趣区域中的凝块。 在用微泡造影剂灌注感兴趣区域之后,治疗换能器元件由位于换能器中的放大器驱动以溶解凝块。 可以使用成像换能器元件和治疗换能器元件进行交织,使得治疗可以对超声图像进行调节,该超声图像显示造影剂微泡的显着破坏,感兴趣区域中微泡的再次灌注,或持续存在 的凝块。
    • 9. 发明申请
    • THERAPY ASSESSMENT WITH ULTRASOUND CONTRAST AGENTS
    • 超声波对比剂的治疗评估
    • US20100298710A1
    • 2010-11-25
    • US12864262
    • 2009-01-23
    • Michalakis AverkiouMarios LampaskisKonstantina Kyriakopoulou
    • Michalakis AverkiouMarios LampaskisKonstantina Kyriakopoulou
    • A61B8/14
    • G06T7/0012A61B8/0833A61B8/481A61B8/543G06T2200/04G06T2207/10016G06T2207/10132G06T2207/20104G06T2207/30096
    • An ultrasonic imaging apparatus and method are described for monitoring the progress of therapy for pathology such as lesions, tumors, and metastases by means of contrast agent imaging. A sequence of images are acquired as a bolus of contrast agent infuses the tissue containing the pathology. A contrast wash-in time parameter is calculated for both the tumor and normal tissue, and a ratio is calculated of the two wash-in time parameters (called WITR) which removes the effects of variations in the procedure from one therapy monitoring session to another. A difference curve of the time-intensity curves of the pathology and normal tissue is also produced, which is similarly immune to procedural variations. The motional effects of respiration can be taken into account by detecting the position of a landmark such as the diaphragm in each of the images of the sequence and discarding from processing those which exhibit a change in the position of the landmark relative to the probe.
    • 描述了超声成像装置和方法,用于通过造影剂成像来监测病理学如病变,肿瘤和转移的治疗进展。 当大量造影剂注入包含病理学的组织时,获取图像序列。 计算肿瘤和正常组织的对比洗涤时间参数,并计算两次洗脱时间参数(称为WITR)的比例,其消除了从一个治疗监测期到另一个治疗监测期的变化的影响 。 还产生了病理学和正常组织的时间 - 强度曲线的差异曲线,其类似地不受程序变化的影响。 可以通过在序列的每个图像中检测诸如隔膜之类的标记的位置来消除呼吸的运动效应,并且从处理那些表现出相对于探针的地标相对位置变化的那些的位置而被考虑。
    • 10. 发明申请
    • RESPIRATORY-GATED THERAPY ASSESSMENT WITH ULTRASONIC CONTRAST AGENTS
    • 超声对照药物的呼吸治疗治疗评估
    • US20100298706A1
    • 2010-11-25
    • US12864273
    • 2009-01-23
    • Michalakis AverkiouMarios LampaskisKonstantina Kyriakopoulou
    • Michalakis AverkiouMarios LampaskisKonstantina Kyriakopoulou
    • A61B8/14
    • G06T7/0012A61B8/0833A61B8/481A61B8/543G06T2200/04G06T2207/10016G06T2207/10132G06T2207/20104G06T2207/30096
    • An ultrasonic imaging apparatus and method are described for monitoring the progress of therapy for pathology such as lesions, tumors, and metastases by means of contrast agent imaging. A sequence of images are acquired as a bolus of contrast agent infuses the tissue containing the pathology. A contrast wash-in time parameter is calculated for both the tumor and normal tissue, and a ratio is calculated of the two wash-in time parameters (called WITR) which removes the effects of variations in the procedure from one therapy monitoring session to another. A difference curve of the time-intensity curves of the pathology and normal tissue is also produced, which is similarly immune to procedural variations. The motional effects of respiration can be taken into account by detecting the position of a landmark such as the diaphragm in each of the images of the sequence and discarding from processing those which exhibit a change in the position of the landmark relative to the probe.
    • 描述了超声成像装置和方法,用于通过造影剂成像来监测病理学如病变,肿瘤和转移的治疗进展。 当大量造影剂注入包含病理学的组织时,获取图像序列。 计算肿瘤和正常组织的对比洗涤时间参数,并计算两次洗脱时间参数(称为WITR)的比例,其消除了从一个治疗监测期到另一个治疗监测期的变化的影响 。 还产生了病理学和正常组织的时间 - 强度曲线的差异曲线,其类似地不受程序变化的影响。 可以通过在序列的每个图像中检测诸如隔膜之类的标记的位置来消除呼吸的运动效应,并且从处理那些表现出相对于探针的地标相对位置变化的位置而被忽略。